Business Articles

Real People

Pfizer’s Biopharma Global Chief Marketing Officer Drew Panayiotou is ‘Radically Obsessed’ with Listening to Patients

For Drew Panayiotou, working at Pfizer comes with an enormous perk: the potential to change the world. That’s why he took the role as the company’s first Biopharma Global Chief Marketing Officer. “Our organization has the power to bring breakthroughs for billions,” says Panayiotou, who joined Pfizer in the fall of 2022. “My job as CMO is to help our organization better understand our healthcare providers and patients so that we can meet them where they are with the information they need at the...

Trusted Voices

Why Compliance Matters and Why Patients Should Care

In 2020, as pharmaceutical companies raced to develop a vaccine in record time, the public got a rare and exciting glimpse into an area of science that’s not usually in the spotlight: drug development. Clinical trials recruited hundreds of thousands of patients, while families in lockdown waited, hoping for regulatory approval of a COVID-19 vaccine that would change the course of the pandemic. Along the way, those who watched learned a lot about the technical processes involved in creating...

Purpose & Ideals

Net Zero by 2040: How Pfizer is Fighting Climate Change with Ambitious Science Based Goals

In 2015, on the eve of the Paris Agreement, Pfizer was one of the first companies in the world to seek and gain approval of its greenhouse gas emission reduction goal from the Science Based Targets Initiative (SBTi). Since then, leading scientific researchers, together with coalitions such as SBTi, have urged the private and public sectors to increase their commitments to address the growing urgency of the climate crisis. The science is irrefutable; action is required to meet the goals of the Pa...

Purpose & Ideals

How The Pfizer Foundation is Partnering to Improve Health Outcomes for Black Youth

A conversation with Dr. Clyde Glenn, President of the Essie B. & William Earl Glenn Foundation for Better Living In Sunflower County, Mississippi, one of the poorest counties in the nation, The Pfizer Foundation partners at The Glenn Family Foundation (GFF) are working to improve health and life outcomes by addressing the social determinants of health impacting this community.  As defined by the Centers for Disease Control and Prevention, social determinants of health are conditions in the...

Science & Innovation

What Makes an RNA Vaccine Different From a Conventional Vaccine?

Vaccines are one of the greatest health interventions ever developed. They’ve been cited as being as important to keeping communities healthy as having access to clean water and safe sanitation.1 Through scientific investment and ingenuity, today we have multiple vaccine technology platforms that have helped us control and, in some cases, eradicate many healthcare challenges such as polio, river blindness, smallpox, and COVID-19, just to name a few. In 2020, messenger RNA, or mRNA for short...

Real People

Bill Sessa is Ready to Deliver Breakthroughs for Common Diseases

“Despite advances in treatment, cardiovascular disease is still the number one killer worldwide,” says Bill Sessa, who joined Pfizer as Senior Vice President and Chief Scientific Officer for the Internal Medicine Research Unit (IMRU) in February 2022. “For decades, Pfizer has been at the forefront of advancing novel treatments for people living with cardiovascular and other conditions that affect a significant portion of the world’s population," Sessa says. "I’m thrilled to have the chance to...

Purpose & Ideals

Pfizer’s Institute of Translational Equitable Medicine Addresses Equity in Health Research

When it comes to healthcare, the terms “equitable” and "access" often go hand-in-hand. In order to prevent, treat, and identify diseases that disproportionately impact underserved and minority populations, Pfizer believes that research must be directed to the root causes of healthcare disparities. The recently-launched Institute of Translational Equitable Medicine (ITEM) is intended to do just that: work toward a more equitable future of health care. For Aida Habtezion, M.D., who is Pfizer’s...

Purpose & Ideals

Pfizer's Commitment to Supplier Diversity

While it’s easy to recognize the economic and social benefits that suppliers and their communities receive by doing business with a global biopharmaceutical company such as Pfizer, the benefits are far more mutual than they may seem. Applying innovative perspectives gained from working with suppliers that bring diversity, Pfizer is better able to improve patient care through these connections to a more inclusive group of communities, thus improving health for all. One way Pfizer has worked to...

Real People

Ramcess Jean-Louis Is Ready to Build on Pfizer’s Longtime Commitment to Diversity, Equity, and Inclusion

As the new Global Chief Diversity, Equity, and Inclusion (DEI) Officer at Pfizer, Ramcess Jean-Louis is betting that the global biopharmaceutical company that delivered a COVID-19 vaccine in nine months will support the mission of his office with a similar urgency and can-do spirit. “I feel as if I’ve joined an organization that has the mentality and philosophy that nothing is impossible. When we apply that same urgency and attention to the area of diversity, equity and inclusion, the...

Purpose & Ideals

Through Public-Private Partnership, Scientists are Working to Better Understand Gene Therapy and How it Could Help Patients With Rare Diseases

A rare disease is, by its very nature, rare. The CDC defines a rare disease as a condition that affects fewer than 200,000 people in the United States, or no more than one out of every 2,000 people in Europe.1 And yet, rare diseases—which frequently have a genetic component—affect many: there may be as many 7,000 different types of rare diseases, impacting 25 to 30 million people in the United States, according to the National Center for Advancing Translational Sciences.2 Often, rare diseases...

Purpose & Ideals

Collaborative Efforts in Biopharma: Accelerating Vaccine Development

In the year since the pandemic struck, the world has watched one of the greatest real-life dramas of all time unfold: the quest for a vaccine. In the past, drug development and clinical trials were of interest to a relatively small group of scientists, regulators and health care professionals. But with the threat of COVID-19 looming large, time has not been a luxury. The race for a vaccine has become a true spectacle, carrying with it the potential to save untold numbers of lives, globally.The...

Preventing Accidental Poisonings at Home

It’s always important to be aware of unintentional poisonings and to learn about poison prevention. Though many adults may not think a poisoning could happen to them or their children, many parents may not even be aware of what the dangers could be! According to the Centers for Disease Control and Prevention, every 13 seconds, a poison control center in the United States answers a call about a possible poisoning with more than 90% of these exposures occurring in the home. Additionally...